Pmda - Pharmaceuticals and Medical Devices Agency

Regulatory Science/The Science Board/Standard Development

The 3rd Subcommittee on Rare Cancers

Press Release

Date and Time:February 17, 2017 from 4pm to 6pm

Agenda / List of Handouts

  1. Pathophysiological Mechanism of Rare Disease Using Patient-Derived iPS Cells and Drug Discovery (Dr. Junya Toguchida, a Member of the Subcommittee)
  2. Study of Hematological Immunity Disorders Using iPS Cells (Dr. Toshio Heike, a Member of the Subcommittee)
  3. Development of Gene Therapy and Immunotherapy (Dr. Kenzaburo Tani, a Member of the Subcommittee)
  4. Points to Consider and Future Plan
List of Handouts
  • Document 1 Responsible Party (Draft)
  • Document 2 The 2nd Subcommittee Minutes Summary
  • Document 3 The 1st-2nd Subcommittee Discussion Summary
  • Document 4 Lecture Materials (Dr. Junya Toguchida, a Member)
  • Document 5 Lecture Materials (Dr. Toshio Heike, a Member)
  • Document 6 Lecture Materials (Dr. Kenzaburo Tani, a Member)